Claris Lifesciences Limited
| Report Date | Research house | Description | Reco | At Price | Target Price | UpSide
/DownSide | Download |
|
24-May-17
|
Nirmal Bang Sec
|
Revenues
Claris 4Q-FY17 consolidated revenue at Rs 2210m were in..
|
Buy
|
339
|
480
|
41.6
|
|
|
23-Jan-17
|
Nirmal Bang Sec
|
As regards EV/sales, the deal appears even more attractive at 5.5..
|
|
358
|
480
|
34.1
|
|
|
23-Jan-17
|
Nirmal Bang Sec
|
. Update on Form 483 observations and ongoing regulatory complian..
|
BUY
|
282
|
480
|
70.2
|
|
|
16-Dec-16
|
Nirmal Bang Sec
|
Closes Long-drawn Injectable Business Divestment Deal
|
Buy
|
358
|
480
|
34.1
|
|
|
10-Dec-12
|
Anand Rathi
|
-
|
|
|
|
|
|
asdsa
Upcoming Events and Recent Updates
No Recent Updates.